Gupta, Pankaj <br/><br/>
Lack of effect of tofacitinib (CP-690,550) on the pharmacokinetics of the CYP3A4 substrate midazolam in healthy volunteers: confirmation of in vitro data.  [electronic resource] 

 -  British journal of clinical pharmacology  Jul 2012 
 - 109-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.2012.04168.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP3A--metabolism<br/>Drug Interactions<br/>Female<br/>GABA Modulators--pharmacokinetics<br/>Half-Life<br/>Humans<br/>Janus Kinases--antagonists & inhibitors<br/>Male<br/>Metabolic Clearance Rate<br/>Midazolam--pharmacokinetics<br/>Middle Aged<br/>Piperidines<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>Young Adult